Indivior Pharmaceuticals, Inc.
INDV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001625297
In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Indivior Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +5 vs. Q2 2024
- Shares held
- 73.0M
- +8.24M (+12.7%) vs. Q2 2024
- Total value
- $720.7M
- −$307.9M (−29.9%) vs. Q2 2024
- New holders
- 27
- 28 more added
- Sold out
- 22
- 30 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INDV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $4.98B |
| Q1 2026 | 290 | $3.89B |
| Q4 2025 | 259 | $4.36B |
| Q3 2025 | 198 | $2.68B |
| Q2 2025 | 120 | $1.58B |
| Q1 2025 | 116 | $866.0M |
| Q4 2024 | 113 | $974.8M |
| Q3 2024 | 103 | $720.7M |
| Q2 2024 | 99 | $1.03B |
| Q1 2024 | 95 | $1.38B |
| Q4 2023 | 76 | $974.7M |
| Q3 2023 | 76 | $1.53B |
| Q2 2023 | 60 | $1.46B |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Indivior Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Seas Capital LP | 13,030,027 | $127.0M | 21.48% | +400,001+3.2% | Added |
| Bank of Montreal | 11,960 | – | – | +2,217+22.8% | Added |
| M&G Plc | 110,039 | – | – | −7,507−6.4% | Reduced |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −1,141,377−100.0% | Sold out |
| Premier Fund Managers Ltd | 0 | $0 | 0.00% | −871,133−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −497,555−100.0% | Sold out |
| Exor Capital LLP | 0 | $0 | 0.00% | −474,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −277,197−100.0% | Sold out |
| Corbin Capital Partners, L.P. | 0 | $0 | 0.00% | −199,574−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −179,497−100.0% | Sold out |
| Renaissance Group LLC | 0 | $0 | 0.00% | −130,529−100.0% | Sold out |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0 | $0 | 0.00% | −126,542−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −70,500−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −63,521−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −41,695−100.0% | Sold out |
| Royal London Asset Management Ltd | 0 | $0 | 0.00% | −35,416−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −25,236−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −20,022−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −17,398−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −11,672−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,098−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,489−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −5,505−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,210−100.0% | Sold out |
| Forsta Ap-Fonden | 0 | $0 | 0.00% | −29,908−100.0% | Sold out |
| ICA Group Wealth Management, LLC | – | – | – | – | Not filed |